Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
We are transparent about the current state of the evidence and discuss it with every patient during consultation.
This range helps doctors tailor treatments based on how bad the deficiency is and how well the patient responds
Initiated biologics included in this analysis were adalimumab, certolizumab, etanercept, infliximab, ustekinumab, secukinumab, ixekizumab, brodalumab, bimekizumab, guselkumab, risankizumab, tildrakizumab, and available biosimilars (adalimumab, etanercept, and infliximab)
Cost: The cost of injections, especially if administered regularly, can be higher than oral supplements
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
